MEDICINOVA, INC. (MNOV) Operating cash flow 2016–2025
MEDICINOVA, INC. (MNOV) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$9.8MFY2025 · since FY2016: -$6.5M → -$9.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.8M | +7.8% |
| FY2024 | -$10.6M | -43.2% |
| FY2023 | -$7.4M | +42.4% |
| FY2022 | -$12.9M | -37.6% |
| FY2021 | -$9.4M | +13.3% |
| FY2020 | -$10.8M | -18.6% |
| FY2019 | -$9.1M | -0.1% |
| FY2018 | -$9.1M | -31.6% |
| FY2017 | -$6.9M | -5.8% |
| FY2016 | -$6.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MNOV financial trends
MNOV RevenueMNOV Net incomeMNOV Net marginMNOV Gross profitMNOV Gross marginMNOV Operating incomeMNOV Operating marginMNOV Free cash flowMNOV Capital expendituresMNOV Return on equityMNOV Stock buybacksMNOV Dividends paidMNOV Total assetsMNOV Total liabilitiesMNOV Shareholders’ equityMNOV overview →